Predicting Rheumatoid Arthritis Treatment Success: New Biomarker Breakthrough

Predicting Rheumatoid Arthritis Treatment Success New Biomarker Breakthrough   Key Takeaways Rheumatoid arthritis is a chronic systemic autoimmune disease affecting approximately 1 percent of the global population. Despite major advances in biologic and targeted synthetic disease modifying antirheumatic drugs, treatment success remains highly variable. Approximately

Predicting Rheumatoid Arthritis Treatment Success: New Biomarker Breakthrough